Selvedge Venture
Pre-seed to Series A investor in biotech and data-driven start-ups tackling age-related disease
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+
- Sector focus
- AI & Data, Healthtech, Biotech & Life Sciences
- Cheque size
- €1.5M–€3M
- Fund size
- Undisclosed
- Founded
- 2020
- Website
- selvedgeventure.com
Selvedge Venture invests in pre-seed, seed and Series A-ready start-ups working on age-related medical conditions, specifically metabolic syndrome, cancer and neurodegenerative disease. It concentrates on companies at the intersection of biotechnology, machine learning and integrated health data.
The firm was set up around 2020 by founding partner Alasdair Thong and co-founder and general partner Robert Thong, who previously co-led the life sciences group at Capgemini. Its portfolio includes Carbometrics, Ochre Bio, Sanome, Multiomic, Exogene and Avro Life Science. Its offering is restricted to professional investors.
← All investors · Is this your organisation? Request an update
More investors in the directory
FirstPartyCapital
Specialist investor in AI, data and outcomes-based technology for the marketing and advertising sector
Elbow Beach
Early-stage investor in British clean technologies that cut emissions while improving customer economics
SFV
Seed to Series B investor in urban, energy and industrial infrastructure technology
Zinal Growth
Growth investor partnering with founders building generational technology companies
Rockley Group
Invests in and advises technology businesses focused on sustainability, energy and resource efficiency
Tagus Capital
Deep-tech fund backing AI, blockchain, quantum, space and robotics founders from Oxford, Cambridge and London
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.